These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 23625986)
21. Clinical use of sildenafil in pulmonary artery hypertension. Singh TP Expert Rev Respir Med; 2010 Feb; 4(1):13-9. PubMed ID: 20387288 [TBL] [Abstract][Full Text] [Related]
22. Priapism in an infant with sickle cell trait after cardiac transplant. Bacsu CD; Metcalfe PD Urology; 2012 Oct; 80(4):928-30. PubMed ID: 22901818 [TBL] [Abstract][Full Text] [Related]
23. Safety of sildenafil in infants*. Samiee-Zafarghandy S; Smith PB; van den Anker JN Pediatr Crit Care Med; 2014 May; 15(4):362-8. PubMed ID: 24583505 [TBL] [Abstract][Full Text] [Related]
24. Hemodynamic and gas exchange effects of sildenafil in patients with chronic obstructive pulmonary disease and pulmonary hypertension. Blanco I; Gimeno E; Munoz PA; Pizarro S; Gistau C; Rodriguez-Roisin R; Roca J; Barberà JA Am J Respir Crit Care Med; 2010 Feb; 181(3):270-8. PubMed ID: 19875684 [TBL] [Abstract][Full Text] [Related]
25. Treatment of pulmonary hypertension in children with chronic lung disease with newer oral therapies. Krishnan U; Krishnan S; Gewitz M Pediatr Cardiol; 2008 Nov; 29(6):1082-6. PubMed ID: 18594787 [TBL] [Abstract][Full Text] [Related]
26. Impact of sildenafil on survival of patients with idiopathic pulmonary arterial hypertension. Zeng WJ; Sun YJ; Gu Q; Xiong CM; Li JJ; He JG J Clin Pharmacol; 2012 Sep; 52(9):1357-64. PubMed ID: 21956607 [TBL] [Abstract][Full Text] [Related]
27. Management of pulmonary arterial hypertension in the neonatal unit. Krishnan U Cardiol Rev; 2010; 18(2):73-5. PubMed ID: 20160532 [TBL] [Abstract][Full Text] [Related]
28. Phosphodiesterase type 5 inhibitors in pulmonary arterial hypertension. Montani D; Chaumais MC; Savale L; Natali D; Price LC; Jaïs X; Humbert M; Simonneau G; Sitbon O Adv Ther; 2009 Sep; 26(9):813-25. PubMed ID: 19768639 [TBL] [Abstract][Full Text] [Related]
29. Role of oral sildenafil in severe pulmonary arterial hypertension: clinical efficacy and dose response relationship. Garg N; Sharma MK; Sinha N Int J Cardiol; 2007 Sep; 120(3):306-13. PubMed ID: 17174417 [TBL] [Abstract][Full Text] [Related]
30. Impact of sildenafil therapy on pulmonary arterial hypertension in adults with congenital heart disease. Lu XL; Xiong CM; Shan GL; Zhu XY; Wu BX; Wu GH; Liu ZH; Ni XH; Cheng XS; Gu Q; Zhao ZH; Zhang DZ; Li WM; Zhang C; Tian HY; Guo YJ; Guo T; Liu HM; Zhang WJ; Gu H; Huang SA; Chen JY; Wu WF; Huang K; Li JJ; He JG Cardiovasc Ther; 2010 Dec; 28(6):350-5. PubMed ID: 20637015 [TBL] [Abstract][Full Text] [Related]
31. [Phosphodiesterase type 5 inhibitors in the treatment of pulmonary arterial hypertension]. Kiliçkesmez K; Küçükoğlu MS Anadolu Kardiyol Derg; 2010 Sep; 10 Suppl 2():16-8. PubMed ID: 20819751 [TBL] [Abstract][Full Text] [Related]
32. Phosphodiesterase 5 inhibition with sildenafil reverses exercise oscillatory breathing in chronic heart failure: a long-term cardiopulmonary exercise testing placebo-controlled study. Guazzi M; Vicenzi M; Arena R Eur J Heart Fail; 2012 Jan; 14(1):82-90. PubMed ID: 22067410 [TBL] [Abstract][Full Text] [Related]
34. Sarcoidosis-associated pulmonary hypertension: acute vasoresponsiveness to inhaled nitric oxide and the relation to long-term effect of sildenafil. Milman N; Svendsen CB; Iversen M; Videbaek R; Carlsen J Clin Respir J; 2009 Oct; 3(4):207-13. PubMed ID: 20298406 [TBL] [Abstract][Full Text] [Related]
35. Not just for men. Prat NM; Sánchez-Dalmau BF; Foroozan R Surv Ophthalmol; 2011; 56(2):173-7. PubMed ID: 21035828 [TBL] [Abstract][Full Text] [Related]
36. Pulmonary artery hypertension in heart transplant recipients: how much is too much? De Santo LS; Romano G; Maiello C; Buonocore M; Cefarelli M; Galdieri N; Nappi G; Amarelli C Eur J Cardiothorac Surg; 2012 Nov; 42(5):864-9; discussion 869-70. PubMed ID: 22402452 [TBL] [Abstract][Full Text] [Related]